Athyrium Opportunities IV Acquisition 2 LP

Insider Reports History

Entity
Company
Location
505 Fifth Avenue, Floor 18, New York, NY
Signature
/s/ Athyrium Opportunities IV Acquisition 2 LP, by Athyrium Opportunities Associates IV LP, its General Partner, by Athyrium Opportunities Associates IV GP LLC, its General Partner, by Andrew Hyman, Senior Vice President, Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Athyrium Opportunities IV Acquisition 2 LP:

Stock Role Class Num Shares Value Price $ Report Date Ownership
RVL Pharmaceuticals plc 10%+ Owner Ordinary Shares 6.45M $201K $0.03 Aug 8, 2022 Indirect

Insider Reports Filed by Athyrium Opportunities IV Acquisition 2 LP

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVLP RVL Pharmaceuticals plc Aug 8, 2022 0 $0 3 Aug 12, 2022 10%+ Owner